ReviewCureus2025

Empagliflozin and Cardiovascular Outcomes: A Systematic Review of Randomized Controlled Trials in Populations With Diabetes and Heart Failure.

Farrukh Ansar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.